IndiCell: Individualized pluripotent stemcell-based treatment

The project's overall aim is to develop and consolidate a sustainable, collaborative and world leading innovation milieu (IndiCell) based on Individual cell therapy that will continue also after the end of this funding. IndiCell will derive state-of-the-art workflows addressing generic steps in the process of deriving iPSC therapies products using our own world-leading projects as models. Those workflows and IndiCell’s competence will decrease cost, labour, time and clear the regulatory path for future iPSC therapy projects in Sweden, in addition to lowering the threshold for innovations.